On December 1, 2025, Tecan Group acquired the assets of Wako Automation, including the Director™ scheduling software, to enhance its laboratory automation capabilities and expand its product portfolio in response to growing demand for integrated automation solutions in the biopharma sector.
Information on the target
The Tecan Group, a prominent player in laboratory automation, has successfully acquired the assets of Wako Automation, which includes the highly regarded Director™ scheduling software and select hardware modules. This strategic acquisition was finalized on December 1, 2025, and is poised to enhance Tecan's offerings in the automation sector significantly.
By integrating Wako Automation's advanced scheduling capabilities, Tecan aims to provide its customers with enhanced flexibility and efficiency in managing complex workflows. The acquisition aligns with Tecan's vision to expand its market presence beyond traditional liquid-handling solutions, reinforcing its leadership in the laboratory automation industry.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry overview in the target’s specific country
Switzerland is recognized as a global hub for life sciences and biotechnology, with a robust infrastructure supporting research and development. The laboratory automation sector in Switzerland is experiencing sig
Similar Deals
Tecan Group
invested in
Wako Automation assets
in 2025
in a Other deal
Disclosed details
Revenue: $1,062M